The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Renal hyperfiltration related to diabetes mellitus and obesity in human disease
Open accessAbstract
High intraglomerular pressure is associated with renal hyperfiltration, leading to the initiation and progression of kidney disease in experimental models of diabetes mellitus (DM). In humans, hyperfiltration is observed in patients with type 1 and type 2 DM, and is also seen in patients with pre-diabetic conditions, such as the metabolic syndrome. From a mechanistic perspective, both vascular and tubular factors likely contribute to the pathogenesis of hyperfiltration. Until now, human studies have primarily focused on the use of medications that inhibit the renin angiotensin system to reduce efferent vasoconstriction and thereby improve hyperfiltration. More recent advances in the development of investigational adenosine antagonists and inhibitors of sodium glucose co-transport may help to elucidate tubular factors that contribute to afferent vasodilatation. In this review, we summarize available data from experimental and human studies of type 1 and type 2 DM and obesity to provide an overview of factors that contribute to the hyperfiltration state. We have focused on the renin angiotensin system, cyclooxygenase-2 system, nitric oxide, protein kinase C and endothelin as vascular determinants of hyperfiltration. We also discuss relevant tubular factors, since experimental models have suggested that inhibition of sodium-glucose cotransport may be renoprotective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
List, J. F., Woo, V., Morales, E., Tang, W., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc08-1863 · Cited by 698
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Is obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
de Paula, R. B., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000105624.68174.00 · Cited by 207
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
List, J. F., & Whaley, J. M. (2011) · Kidney International · doi:10.1038/ki.2010.512 · Cited by 184
Impaired fasting glucose is associated with renal hyperfiltration in the general population
Melsom, T., Mathisen, U. D., Ingebretsen, O. C., Jenssen, T. G., Njølstad, I., Solbu, M. D., Toft, I., & Eriksen, B. O. (2011) · Diabetes Care · doi:10.2337/dc11-0235 · Cited by 134
Research works printed but not linked: 73
- Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993;265:F477-F486. · DOI · Paper page
- 10.1016/0026-0495(87)90070-9 · DOI · Paper page
- 10.1038/ki.1981.33 · DOI · Paper page
- 10.1073/pnas.82.17.5963 · DOI · Paper page
- Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999;10:2569-2576. · DOI · Paper page
- Park SK, Kang SK. Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med 1995;10:48-53. · DOI
- 10.1007/s00125-009-1268-0 · DOI · Paper page
- 10.1093/ndt/16.7.1382 · DOI
- 10.1007/s00125-010-1794-9 · DOI · Paper page
- 10.1038/sj.ki.5002160 · DOI · Paper page
- 10.2174/157339908786241151 · DOI
- 10.1172/JCI112521 · DOI · Paper page
- 10.2337/diabetes.49.7.1258 · DOI
- 10.1038/ki.1993.183 · DOI · Paper page
- Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000;11:71-79. · DOI · Paper page
- O'Byrne S, Forte P, Roberts LJ, Morrow JD, Johnston A, Anggård E, Leslie RD, Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000;49:857-862. · DOI
- 10.3317/jraas.2004.006 · doi:10.3317/jraas.2004.006
- 10.2337/db07-1230 · DOI
- 10.2337/dc09-2340 · DOI
- 10.1152/ajprenal.00574.2007 · DOI
- Ichihara A, Imig JD, Navar LG. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure. Hypertension 1999;34:843-847. · DOI
- 10.1172/JCI10228 · DOI · Paper page
- 10.1038/ki.1996.265 · DOI · Paper page
- Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006;17:1703-1709. · DOI
- 10.2337/dc08-1609 · DOI
- Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000;14:439-447. · DOI · Paper page
- 10.1126/science.272.5262.728 · DOI · Paper page
- Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 2006;55:3112-3120. · DOI · Paper page
- 10.1016/S0895-7061(98)00094-6 · doi:10.1016/s0895-7061(98)00094-6
- 10.3109/00365519609088813 · doi:10.3109/00365519609088813
- 10.1007/s001250051308 · DOI
- 10.1016/S0026-0495(98)90314-6 · doi:10.1016/s0026-0495(98)90314-6
- 10.2337/diacare.21.6.1004 · DOI
- Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int 1994;46:376-381. · doi:10.1038/ki.1994.284
- Sørensen SS, Madsen JK, Pedersen EB. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994;266:F411-F418. · doi:10.1152/ajprenal.1994.266.3.f411
- 10.1161/01.CIR.0000118499.69469.51 · DOI · Paper page
- 10.1111/j.1365-2125.2005.02503.x · doi:10.1111/j.1365-2125.2005.02503.x
- 10.1681/ASN.2009060593 · DOI · Paper page
- 10.1681/ASN.2008050482 · DOI · Paper page
- Aires I, Calado J. BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus. Curr Opin Investig Drugs 2010;11:1182-1190.
- 10.1681/ASN.2007060721 · DOI
- 10.1111/j.1365-2362.2005.01497.x · DOI
- 10.1097/01.ASN.0000051700.07403.27 · DOI · Paper page
- Vallon V, Wead LM, Blantz RC. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J Am Soc Nephrol 1995;5:1761-1767. · DOI
- 10.1038/sj.bjp.0703829 · DOI · Paper page
- Malatiali S, Francis I, Barac-Nieto M. Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats. Exp Diabetes Res 2008;2008:305403. · DOI
- Strojek K, Yoon KH, Hruba V, Elze M, Langkilde AM, Parikh S. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial. Diabetes Obes Metab 2011;13:928-938. · DOI · Paper page
- 10.1056/NEJMoa0912613 · DOI · Paper page
- Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, Smits P. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension 1999;34:1080-1085. · DOI
- 10.2337/dc10-0767 · DOI
- 10.1152/ajpregu.00853.2005 · DOI
- 10.1152/ajpregu.00693.2005 · DOI
- 10.1016/S1056-8727(02)00196-4 · DOI
- 10.1016/S0168-8227(01)00260-1 · DOI
- 10.2337/diabetes.54.7.2206 · DOI
- 10.1007/s00125-005-0002-9 · DOI
- 10.1152/ajprenal.00421.2010 · DOI
- 10.2215/CJN.02350607 · DOI
- 10.1159/000110566 · DOI
- 10.1038/ncpneph0565 · DOI
- 10.1093/ndt/gfq008 · DOI
- 10.1053/j.ajkd.2010.03.017 · DOI
- Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996;28:127-132. · DOI · Paper page
- 10.1161/01.HYP.0000132568.71409.a2 · DOI
- 10.1080/10739680701283018 · DOI
- 10.1097/01.ASN.0000068462.38661.89 · DOI · Paper page
- Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822. · DOI · Paper page
- 10.1007/s12020-009-9224-9 · DOI
- 10.1159/000185377 · doi:10.1159/000185377
- 10.1093/ndt/gfn379 · DOI · Paper page
- 10.2215/CJN.03691106 · DOI
- 10.2337/dc09-1303 · DOI
- 10.1111/j.1464-5491.2010.03121.x · DOI
Cited by
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
Cherney, D. Z., Perkins, B. A., Soleymanlou, N., Har, R., Fagan, N., Johansen, O., Woerle, H.-J., von Eynatten, M., & Broedl, U. C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-28 · Cited by 470
Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond
Zhao, H., Alam, A., Soo, A. P., George, A. J. T., & Ma, D. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.025 · Cited by 360
Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
Gnudi, L., Coward, R. J. M., & Long, D. A. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.07.002 · Cited by 332
Metadata
- Authors
- Sasson, A. N.
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 3
- Issue
- 1
- Pages
- 1
- ISSN
- 1948-9358 (ISSN-L)
- OpenAlex
- W2075475582
- Cited by
- 158
- References
- 7
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal hyperfiltration related to diabetes mellitus and obesity in human disease. https://app.cochat.ai/papers/10.4239/wjd.v3.i1.1
- The paper
- Sasson, A. N. (2012). Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World Journal of Diabetes. https://doi.org/10.4239/wjd.v3.i1.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.